Published Jun 13, 2021
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Delve into the billionaire space race's implications for industry transformation, unravel the complexities of remote work dynamics and wealth taxation, and critically examine the controversial FDA approval of Biogen's Alzheimer's drug, highlighting its impact on regulatory and economic practices.

Topics covered
Popular Clips
Episode Highlights
Related Episodes


E40: A Bestie gets COVID, Delta breakthrough, Billionaire Space Race & more
Answers 383 questions

E144: Biden targets Elon, BRICS challenges the West, Tiger hit piece & more
Answers 383 questions

E128: Google enters AI wars, Druck’s warning, Trump crushes CNN & more
Answers 383 questions













